Research graph
References from First successful allogeneic hematopoietic stem cell transplantation in STING-associated vasculopathy of infancy—A case report. Local targets link to admitted publications; unresolved targets remain external evidence.
Activated STING in a Vascular and Pulmonary Syndrome
10.1056/nejmoa1312625 · 2014 · External reference
Failure to thrive, interstitial lung disease, and progressive digital necrosis with onset in infancy
10.1016/j.jaad.2015.10.007 · 2016 · External reference
Case report: JAK1/2 inhibition with baricitinib in the treatment of STING-associated vasculopathy with onset in infancy
2023 · External reference
Use of Tofacitinib for infant-onset STING-associated vasculopathy: A case report from China
2022 · External reference
Stimulator of Interferon Genes-Associated Vasculopathy With Onset in Infancy: A Systematic Review of Case Reports
2020 · External reference
Normalized Interferon Signatures and Clinical Improvements by IFNAR1 Blocking Antibody (Anifrolumab) in Patients with Type I Interferonopathies
10.1007/s10875-024-01826-2 · 2024 · External reference
Sustained Interferon Signature Suppression With Anifrolumab in a Patient With STING-Associated Vasculopathy with Onset in Infancy Refractory to JAK Inhibitor and Dazukibart Therapy
10.1002/art.43145 · 2025 · External reference
Successful Treatment of Stimulator of Interferon Genes-Associated Vasculopathy of Infantile Onset SAVI Syndrome With Anifrolumab
10.1001/jamadermatol.2024.2160 · 2024 · External reference
Retinal vasculopathy in STING-associated vasculitis of infancy (SAVI)
10.1093/rheumatology/keab297 · 2021 · External reference
Type I interferon-independent T cell impairment in a Tmem173 N153S/WT mouse model of STING associated vasculopathy with onset in infancy (SAVI)
2020 · External reference
STING palmitoylation as a therapeutic target
10.1038/s41423-019-0205-5 · 2019 · External reference
Janus Kinase Inhibitors in the Treatment of Type I Interferonopathies: A Case Series From a Single Center in China
2022 · External reference
Efficacy and Safety of Janus Kinase Inhibitors in Type I Interferon-Mediated Monogenic Autoinflammatory Disorders: A Scoping Review
10.1007/s13555-021-00517-9 · 2021 · External reference
Lung Inflammation in STING-Associated Vasculopathy with Onset in Infancy (SAVI)
2022 · External reference
STING-associated vasculopathy develops independently of IRF3 in mice
10.1084/jem.20171351 · 2017 · External reference
A 17-Year-Old Girl Diagnosed With STING-Associated Vasculopathy With Onset in Infancy (SAVI) After Lung Transplantation
10.1016/j.chest.2022.05.025 · 2022 · External reference
Lung Transplantation under a Janus Kinase Inhibitor in Three Patients with SAVI Syndrome
10.1007/s10875-023-01595-4 · 2023 · External reference
Single-cell RNA-sequencing of PBMCs from SAVI patients reveals disease-associated monocytes with elevated integrated stress response
2023 · External reference
Radioresistant cells initiate lymphocyte-dependent lung inflammation and IFNγ-dependent mortality in STING gain-of-function mice
2022 · External reference
A novel STING variant triggers endothelial toxicity and SAVI disease
10.1084/jem.20232167 · 2024 · External reference
Overview of STING-Associated Vasculopathy with Onset in Infancy (SAVI) Among 21 Patients
2020 · External reference
STING-associated vasculopathy with onset in infancy: a familial case series report and literature review
2021 · External reference
Phenotypic spectrum in recessive STING-associated vasculopathy with onset in infancy: Four novel cases and analysis of previously reported cases
10.3389/fimmu.2022.1029423 · 2022 · External reference
STING-associated vasculopathy with onset in infancy (SAVI) presenting with skin lesions
10.1111/pde.15620 · 2024 · External reference
A case of STING-associated vasculopathy with onset in infancy with novel STING1 variant
10.1111/pde.15559 · 2024 · External reference
STING-Associated Vasculopathy with Onset in Infancy: A Review Focusing on Pathophysiology and Treatment Options
10.3390/jmp4040024 · 2023 · External reference
STING-Mediated Lung Inflammation and Beyond
10.1007/s10875-021-00974-z · 2021 · External reference
Emerging concepts and treatments in autoinflammatory interferonopathies and monogenic systemic lupus erythematosus
10.1038/s41584-024-01184-8 · 2025 · External reference
